Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Onto Innovation (ONTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Onto Innovation — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.59 (market cap $4.59B), while Onto Innovation trades at $294.27 (market cap $14.36B). The key difference: Onto Innovation is far larger — about 3.1× Definium Therapeutics Inc. Common Shares's market cap, and Onto Innovation is more actively traded (761,617 versus 2,103,937). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Onto Innovation for 5 Days on average.
| DFTX | ONTO | |
|---|---|---|
Market Cap | $4.59B | $14.36B |
Volume | 2,103,937 | 761,617 |
Sector | Health | Technology |
52-Week High | $48.45 | $378.45 |
52-Week Low | $10.68 | $121.34 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $3.55B | $13.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →
